Viral Fusion Protein Inhibitors
- Name
- Viral Fusion Protein Inhibitors
- Accession Number
- DBCAT000219
- Description
Drugs that are designed to block the action of VIRAL FUSION PROTEINS and prevent VIRUSES from entering the cell.
- Drugs
Drug Drug Description Enfuvirtide An HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals. Leronlimab A humanized monoclonal antibody being investigated Maraviroc A CCR5 co-receptor antagonist used with other antiretroviral medications to treat CCR5-tropic HIV-1 infection. BMS-488043 Investigated for use/treatment in HIV infection. Aplaviroc Investigated for use/treatment in HIV infection. Fostemsavir An antiretroviral HIV-1 attachment inhibitor targeted against the gp120 subunit within the HIV-1 gp160 envelope glycoprotein. - Drugs & Drug Targets